Video Experimental Relacionado

Updated: Jun 30, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

Las metodologías de nuevo enfoque en la enfermedad de Crohn vinculan los subtipos de enfermedades moleculares con los

Harrison M Penrose^1,2, Saptarshi Sinha³, Courtney Tindle^3,4

¹HUMANOIDTM Center of Research Excellence (CoRE), University of California San Diego, La Jolla, CA, 92093.

American journal of physiology. Gastrointestinal and liver physiology

|February 10, 2026

Resumen

Los organoides derivados de pacientes (DOP) son ahora modelos predictivos para los subtipos de la enfermedad de Crohn (EC), que vinculan los perfiles moleculares con los resultados clínicos. Esto hace avanzar la investigación de enfermedades inflamatorias y el desarrollo terapéutico.

Área de la Ciencia:

Enfermedades Inflamatorias del Intestino Investigación de la Enfermedad del Intestino.
La medicina traslacional es una medicina traslacional.
Tecnología Organoide Tecnología Organoide.

Sus antecedentes:

La toma de decisiones clínicas para la enfermedad de Crohn (EC) carece de modelos preclínicos predictivos.
Los organoides derivados de pacientes (DOP) ofrecen una vía prometedora para el desarrollo de tales modelos.

Objetivo del estudio:

Transformar las DOP en vehículos predictivos para la CD mediante la abstracción de características esenciales de los tejidos humanos.
Para anclar prospectivamente los fenotipos moleculares derivados de la DOP a los resultados clínicos del mundo real.

Principales métodos:

Estableció un biobanco vivo de DOP colónicas derivadas de células madre adultas.
Se han definido dos subtipos moleculares de CD: CD Infecciosa por Inmunodeficiencia (IDICD) y CD Fibrosténico Inducido por Estrés y Senescencia (S2FCD).
Principios de abstracción aplicados para desarrollar metodologías de nueva aproximación (NAM) de próxima generación.

Principales resultados:

El fenotipo molecular S2FCD se correlaciona con la actividad basal y progresiva de la enfermedad del colon.
El fenotipo molecular IDICD se asocia con la cirugía ileocecal previa, el comportamiento de la enfermedad penetrante y la actividad de la enfermedad ileal.
Las DOP demostradas como plataformas dinámicas que capturan la trayectoria de la enfermedad.

Conclusiones:

Las DOP pueden servir como plataformas predictivas para enfermedades inflamatorias, permitiendo estudios similares a ensayos clínicos.
La disfunción inmune del colon puede ser un factor clave de la CD ileal.
Este marco avanza el uso de los NAM más allá de la oncología en las enfermedades inflamatorias.

Palabras clave:

Metodologías de nuevo enfoque metodologías de nuevo enfoque.enfermedad inflamatoria del intestino enfermedad inflamatoria del intestino.Los organoides derivados del paciente.terapéutica personalizada para el tratamiento de la enfermedad.modelos predictivos de enfermedades de los modelos predictivos de enfermedades.

Más Videos Relacionados

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Videos de Conceptos Relacionados

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...